Analytical Data
-
Gene name
FAM81B
- Application
-
Alternative Names
FAM81BProtein FAM81B
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96LP2
-
Expression Region
1-452aa
-
AA Sequence
MQLQFLGTLA SSEKRKKSQR LFFKNIKSTK NKAGKASIMS SDTNVNKSAS PTATAEEQPV EPDGPLPGSD NNQEKKVRLS PAKMSTKNST DLVEYVDKSH AFLPIIPNTQ RGQLEDRLNN QARTIAFLLE QAFRIKEDIS ACLQGTHGFR KEESLARKLL ESHIQTITSI VKKLSQNIEI LEDQIRARDQ AATGTNFAVH EINIKHLQGV GDLRGRVARC DSSIVKLSGD IHLFRQEHRQ IEKAIQEFVP ALETLSKNLD MKVMQLLGKI ETASPEQTSN LKMVQGDYRH EMNLLEFKFH SLSSNLYEEV ENNKKWTENQ FLKYRKDHLG HINECLKVLQ EKLEKSENKM EEKLLQLSSK VENFINTQKQ ETQLSKVKHM ENKLSKKMEQ MEKQIWGELE TMQNEYQSGF KSIHDSLSSL QQIQKTKMDL EKYKVQKDLK KLQRKIVELQ EV
-
Molecular Weight
52.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM81B, a member of the FAM81 family of proteins, has garnered increasing attention in recent years due to its potential role in various cellular processes and diseases. Initially identified as a protein involved in cell signaling, FAM81B has been implicated in cancer progression and immune responses. Research suggests that FAM81B may interact with other key signaling molecules, influencing pathways such as the PI3K-Akt and MAPK pathways, which are critical for cell proliferation and survival. Moreover, aberrations in FAM81B expression have been linked to tumors and other pathological conditions, highlighting its importance as a potential biomarker for diagnosis and therapeutic targets. Experimental studies utilizing recombinant FAM81B protein have enhanced our understanding of its structure, function, and interactions at the molecular level. Investigating FAM81B through recombinant technologies allows researchers to explore its roles in vivo and in vitro, providing insights into how alterations in its function contribute to diseases. Furthermore, understanding FAM81B's mechanisms of action could pave the way for developing novel therapeutic strategies that target its pathways, offering hope for more effective treatments for conditions associated with its dysregulation. Overall, the study of FAM81B recombinant protein is crucial for elucidating its biological significance and expanding knowledge on its potential implications in health and disease.
